Search

everythinglearnresearchcommunity

for

Search:↓

The method accurately measures certain steroids in human hair, showing different levels in males and females.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Social isolation makes mice more sensitive to alcohol's effects on brain function.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Neurosteroids may help treat disorders with too much dopamine activity.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Balancing hormones is crucial for women's health and may require hormone therapy.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

PPCM microspheres allow controlled finasteride release over 24 hours.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

PPCM microspheres can effectively release finasteride over 42 days.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.